*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Therapy Related Myelodysplastic Syndrome-Eb2: A Case Report

Author: RAMARAO MANNAM, ARDHANAARI M, DR M SANJEEVA RAO, DR.J.VENKATESWARA RAO
Abstract: Myelodysplastic syndrome (MDS) is a heterogeneous group of haematological disorders. It is mainly categorized bycytopenias. It carries a high risk of progression to acutemyeloid leukemia. The MDSusually signifies with symptoms associated to anemia, and roughly two-thirds will improve thrombocytopenia, aninfrequent, but possibly lethal complication, which improves difficulty in morbidity & treatment, and might be because of distinctive genetic mutations leading to refractory thrombocytopenia, eventually leading to completedecrease insurvival. Here we present a 59 years old male patient admitted with complaints of fever, exertional breathlessness, left eye peri orbital swelling and burning, right thigh swelling and burning. On basis of peripheral smear, HRCT (High Resolution Computed Tomography) & Bone marrow examination he was finally diagnosed asMDS-ERB2.
Keyword: Myelodysplastic syndrome, haematological disorders, cytopenias, HRCT, MDS-ERB2, World Health Organization (WHO)
DOI: https://doi.org/10.31838/ijpr/2020.SP2.441
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free